We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFMD icon
3951
LifeMD
LFMD
$169M
$21K ﹤0.01%
+11,000
New +$24.7K
POLA icon
3952
Polar Power
POLA
$5.93M
$21K ﹤0.01%
+2,357
New +$33.8K
TRML
3953
DELISTED
Tourmaline Bio
TRML
$21K ﹤0.01%
+2,080
New +$33.4K
DVLT
3954
Datavault AI
DVLT
$291M
$21K ﹤0.01%
+13
New +$63.2K
GLS
3955
DELISTED
Gelesis Holdings, Inc.
GLS
$21K ﹤0.01%
+70,822
New +$33.9K
AYLA
3956
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$21K ﹤0.01%
53,600
+5,600
+12% +$3.63K
ZOM
3957
DELISTED
Zomedica Corp.
ZOM
$21K ﹤0.01%
126,000
-889,500
-88% -$182K
AVAH icon
3958
Aveanna Healthcare
AVAH
$2.04B
$20K ﹤0.01%
+25,500
New +$26.7K
BBAI icon
3959
BigBear.ai
BBAI
$1.34B
$20K ﹤0.01%
+30,000
New +$32.4K
CASI
3960
DELISTED
CASI Pharmaceuticals
CASI
$20K ﹤0.01%
10,900
+500
+5% +$992
FRGT icon
3961
Freight Technologies
FRGT
$1.68M
0
IMPP icon
3962
Imperial Petroleum
IMPP
$213M
$20K ﹤0.01%
+5,467
New +$29.6K
INSG icon
3963
Inseego
INSG
$114M
$20K ﹤0.01%
2,400
-27,368
-92% -$411K
JZ
3964
Jianzhi Education Technology Group
JZ
$5.27M
$20K ﹤0.01%
+31
New +$43.2K
LGL.WS
3965
DELISTED
LGL Group Inc Warrants
LGL.WS
$20K ﹤0.01%
102,259
-12,100
-11% -$3.67K
NPCE icon
3966
Neuropace
NPCE
$439M
$20K ﹤0.01%
13,400
+200
+2% +$444
NRXP icon
3967
NRX Pharmaceuticals
NRXP
$135M
$20K ﹤0.01%
1,760
+315
+22% +$3.17K
BRDS
3968
DELISTED
Bird Global, Inc.
BRDS
$20K ﹤0.01%
4,384
+3,404
+347% +$25K
PME
3969
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$20K ﹤0.01%
50,600
-3,100
-6% -$2.13K
BCLI
3970
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$19K ﹤0.01%
787
-2,926
-79% -$109K
HSCS icon
3971
Heart Test Laboratories
HSCS
$8.5M
$19K ﹤0.01%
229
+73
+47% +$11.4K
ILAG icon
3972
Intelligent Living
ILAG
$6.92M
$19K ﹤0.01%
+2,110
New +$48.5K
MATH icon
3973
Metalpha Technology Holding
MATH
$44.8M
$19K ﹤0.01%
37,600
-900
-2% -$545
SONM icon
3974
DNA X Inc
SONM
$5.05M
$19K ﹤0.01%
244
-900
-79% -$74K
AIFF
3975
Firefly Neuroscience
AIFF
$16.7M
$19K ﹤0.01%
1,337
-557
-29% -$13K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.